AR125800A1 - Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n - Google Patents

Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n

Info

Publication number
AR125800A1
AR125800A1 ARP220101207A ARP220101207A AR125800A1 AR 125800 A1 AR125800 A1 AR 125800A1 AR P220101207 A ARP220101207 A AR P220101207A AR P220101207 A ARP220101207 A AR P220101207A AR 125800 A1 AR125800 A1 AR 125800A1
Authority
AR
Argentina
Prior art keywords
peptide compound
amino acid
water
cyclic peptide
acid residue
Prior art date
Application number
ARP220101207A
Other languages
English (en)
Spanish (es)
Inventor
Zengye Hou
Kentarou Seto
Kota Tanaka
Masahide Aoki
Aya SAKON
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AR125800A1 publication Critical patent/AR125800A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP220101207A 2021-05-07 2022-05-06 Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n AR125800A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021079014 2021-05-07
JP2021188473 2021-11-19

Publications (1)

Publication Number Publication Date
AR125800A1 true AR125800A1 (es) 2023-08-16

Family

ID=82156429

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220101207A AR125800A1 (es) 2021-05-07 2022-05-06 Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n

Country Status (11)

Country Link
US (2) US12312379B2 (cg-RX-API-DMAC7.html)
EP (1) EP4086272A1 (cg-RX-API-DMAC7.html)
JP (2) JP7165289B1 (cg-RX-API-DMAC7.html)
KR (2) KR102569348B1 (cg-RX-API-DMAC7.html)
AR (1) AR125800A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022269959A1 (cg-RX-API-DMAC7.html)
CA (1) CA3219081A1 (cg-RX-API-DMAC7.html)
IL (1) IL307918A (cg-RX-API-DMAC7.html)
MX (1) MX2023013098A (cg-RX-API-DMAC7.html)
TW (1) TW202309065A (cg-RX-API-DMAC7.html)
WO (1) WO2022234864A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI852183B (zh) 2011-12-28 2024-08-11 日商中外製藥股份有限公司 胜肽化合物之環化方法
EP3636656A4 (en) 2017-06-09 2021-04-14 Chugai Seiyaku Kabushiki Kaisha METHOD OF SYNTHESIS OF PEPTIDE WITH N-SUBSTITUTED AMINO ACID
US12312297B2 (en) 2018-11-07 2025-05-27 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
KR102994657B1 (ko) 2019-03-15 2026-07-22 추가이 세이야쿠 가부시키가이샤 방향족 아미노산 유도체의 제조 방법
WO2021090856A1 (ja) 2019-11-07 2021-05-14 中外製薬株式会社 立体障害の大きなアミノ酸を含むペプチド化合物の製造方法
EP4043478A4 (en) 2019-11-07 2024-01-03 Chugai Seiyaku Kabushiki Kaisha CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION
KR20230169093A (ko) * 2021-05-07 2023-12-15 추가이 세이야쿠 가부시키가이샤 환상 펩타이드 화합물을 포함하는 제제 및 그의 제조 방법
IL316253A (en) 2022-05-06 2025-01-01 Chugai Pharmaceutical Co Ltd A cyclic compound with selective KRAS inhibitory effect on HRAS and NRAS
TW202428307A (zh) 2022-10-12 2024-07-16 日商中外製藥股份有限公司 包含胜肽、界面活性劑及聚合物的組成物
US20260132169A1 (en) * 2022-10-20 2026-05-14 Chugai Seiyaku Kabushiki Kaisha Method for producing cyclic peptide crystals
JPWO2024096023A1 (cg-RX-API-DMAC7.html) 2022-11-01 2024-05-10
CN120418263A (zh) 2022-12-28 2025-08-01 中外制药株式会社 环肽的纯化方法和生产方法
CN120731215A (zh) 2023-03-20 2025-09-30 中外制药株式会社 用于产生环肽的共晶的方法
TW202506706A (zh) * 2023-04-20 2025-02-16 日商中外製藥股份有限公司 環狀胜肽化合物的製造方法
EP4685150A1 (en) 2023-04-28 2026-01-28 Chugai Seiyaku Kabushiki Kaisha Method for producing amide group-containing compound using n-carboxyamino acid anhydride
CN121532404A (zh) 2023-09-28 2026-02-13 中外制药株式会社 用于使用混合酸酐程序生产肽化合物的方法
EP4759820A1 (en) 2023-12-27 2026-06-17 Chugai Seiyaku Kabushiki Kaisha Method for producing peptide compound using stand-alone-type condensing agent
TW202535902A (zh) 2023-12-27 2025-09-16 日商中外製藥股份有限公司 使用2種以上的添加劑的胜肽化合物的製造方法
WO2025192626A1 (ja) 2024-03-13 2025-09-18 中外製薬株式会社 環構造を有するペプチド化合物の製造方法
WO2026009924A1 (ja) * 2024-07-03 2026-01-08 中外製薬株式会社 ペプチド化合物に含まれるオリゴマーの分析方法
WO2026121297A1 (ja) * 2024-12-04 2026-06-11 ペプチドリーム株式会社 ペプチド及びペイロードを含むコンジュゲート

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010063C2 (nl) 1998-09-10 2000-03-13 Holland Sweetener Co Werkwijze voor de bereiding van neotaam.
JP2003500415A (ja) * 1999-05-26 2003-01-07 アボット・ラボラトリーズ イオン交換樹脂をスカベンジャーとして使用して単離処理を最も少なくしたペプチド合成方法
TWI247012B (en) * 2001-07-19 2006-01-11 Akzo Nobel Nv Process for rapid solution synthesis of peptides
DK2612845T3 (da) * 2010-08-30 2020-11-02 Ajinomoto Kk Aromatisk forbindelse som indeholder specifik forgrening
WO2012171982A1 (en) * 2011-06-16 2012-12-20 Lonza Ltd A process for extraction of peptides and its application in liquid phase peptide synthesis
TWI852183B (zh) 2011-12-28 2024-08-11 日商中外製藥股份有限公司 胜肽化合物之環化方法
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
WO2015179434A1 (en) 2014-05-20 2015-11-26 Ohio State Innovation Foundation Small molecule ras inhibitors
US9944678B2 (en) 2014-12-19 2018-04-17 Bristol-Myers Squibb Company Immunomodulators
US10017540B2 (en) 2015-03-11 2018-07-10 California Institute Of Technology Cyclic peptide binder against oncogenic K-Ras
JP6116782B1 (ja) 2015-08-28 2017-04-19 積水メディカル株式会社 ベンジル化合物
WO2017150732A1 (ja) 2016-03-03 2017-09-08 中外製薬株式会社 チオール基をアミノ基近傍に有するアミノ酸をn末端に持つ非環状ペプチド-核酸複合体、そのライブラリー、およびそれから誘導される環状ペプチド-核酸複合体ライブラリーの製造方法
EP3442991A4 (en) 2016-04-15 2019-11-20 RA Pharmaceuticals, Inc. RAS-BINDING PEPTIDES AND METHODS OF USE
JP6283774B1 (ja) 2016-06-20 2018-02-21 積水メディカル株式会社 新規ジフェニルメタン保護剤
ES2830974T3 (es) 2016-07-25 2021-06-07 Sekisui Medical Co Ltd Nuevo agente protector de xanteno
TW201833127A (zh) 2017-02-27 2018-09-16 日商積水醫療股份有限公司 新穎四環式保護劑
EP3636807A4 (en) 2017-06-09 2021-07-28 Chugai Seiyaku Kabushiki Kaisha CYCLIC PEPTIDE COMPOUND WITH HIGH MEMBRANE PERMEABILITY AND LIBRARY WITH IT
EP3636656A4 (en) 2017-06-09 2021-04-14 Chugai Seiyaku Kabushiki Kaisha METHOD OF SYNTHESIS OF PEPTIDE WITH N-SUBSTITUTED AMINO ACID
CN111479819B (zh) * 2017-12-15 2024-06-14 中外制药株式会社 制备肽的方法和处理碱的方法
KR20200100048A (ko) 2017-12-19 2020-08-25 세키스이 메디칼 가부시키가이샤 신규 알킬디페닐메탄 보호제
GB201805088D0 (en) * 2018-03-28 2018-05-09 Univ Warwick Macrocyclization of peptidomimetics
US12312297B2 (en) 2018-11-07 2025-05-27 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
JP7377679B2 (ja) 2018-11-19 2023-11-10 アムジエン・インコーポレーテツド がん治療のためのkrasg12c阻害剤及び1種以上の薬学的に活性な追加の薬剤を含む併用療法
CN119143631A (zh) 2018-11-30 2024-12-17 中外制药株式会社 用于肽化合物或酰胺化合物的脱保护方法和在固相反应中的树脂脱除方法以及用于生产肽化合物的方法
WO2020122182A1 (ja) 2018-12-12 2020-06-18 中外製薬株式会社 分子内水素結合可能な官能基を有するアミノ酸とそれらのアミノ酸を含むペプチド化合物、およびそれらの製造方法
KR102994657B1 (ko) 2019-03-15 2026-07-22 추가이 세이야쿠 가부시키가이샤 방향족 아미노산 유도체의 제조 방법
EP4017454A4 (en) 2019-08-19 2023-09-20 Savvybaby Pty Ltd. BABY BOTTLE AND ASSOCIATED VALVE SYSTEM
WO2021090856A1 (ja) 2019-11-07 2021-05-14 中外製薬株式会社 立体障害の大きなアミノ酸を含むペプチド化合物の製造方法
EP4043478A4 (en) 2019-11-07 2024-01-03 Chugai Seiyaku Kabushiki Kaisha CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION
JP7709920B2 (ja) 2019-12-27 2025-07-17 中外製薬株式会社 ペプチド化合物の合成法
WO2021246471A1 (ja) 2020-06-03 2021-12-09 中外製薬株式会社 高難度配列の効率的ペプチド縮合法
CN116507763A (zh) 2020-11-05 2023-07-28 中外制药株式会社 抑制由二酮哌嗪形成导致的缺损的肽合成方法
WO2022138891A1 (ja) 2020-12-25 2022-06-30 中外製薬株式会社 N-置換-アミノ酸残基を含むペプチド化合物の製造方法
EP4249496A4 (en) 2020-12-28 2024-11-13 Chugai Seiyaku Kabushiki Kaisha METHOD FOR SUPPORTING AMINO ACIDS ON RESIN FOR SOLID PHASE SYNTHESIS
WO2022234639A1 (ja) 2021-05-07 2022-11-10 中外製薬株式会社 変異型ras(g12d)に対する選択的結合性を示す結合分子
AR125796A1 (es) 2021-05-07 2023-08-16 Chugai Pharmaceutical Co Ltd Compuesto cíclico que tiene una acción inhibitoria selectiva en kras sobre hras y nras
BR112023022875A2 (pt) 2021-05-07 2024-01-23 Chugai Pharmaceutical Co Ltd Uso farmacêutico de composto peptídico cíclico
KR20230169093A (ko) 2021-05-07 2023-12-15 추가이 세이야쿠 가부시키가이샤 환상 펩타이드 화합물을 포함하는 제제 및 그의 제조 방법
EP4206322A3 (en) 2021-12-28 2023-09-06 Chugai Seiyaku Kabushiki Kaisha Polypeptide and method for producing amino acid using same
CA3237911A1 (en) 2021-12-28 2023-07-06 Chugai Seiyaku Kabushiki Kaisha Method for producing n-alkyl amino acid and peptide including n-alkyl amino acid
TW202339786A (zh) 2022-01-21 2023-10-16 日商中外製藥股份有限公司 癌症之治療或預防用醫藥
CA3244999A1 (en) 2022-03-31 2025-06-13 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumors
EP4488283A1 (en) 2022-04-08 2025-01-08 Chugai Seiyaku Kabushiki Kaisha Production method for peptide compound
US20250353875A1 (en) 2022-05-02 2025-11-20 Chugai Seiyaku Kabushiki Kaisha Peptide synthesis method for suppressing defect caused by diketopiperazine formation
IL316253A (en) 2022-05-06 2025-01-01 Chugai Pharmaceutical Co Ltd A cyclic compound with selective KRAS inhibitory effect on HRAS and NRAS
JPWO2023219156A1 (cg-RX-API-DMAC7.html) 2022-05-13 2023-11-16
WO2023219152A1 (ja) 2022-05-13 2023-11-16 中外製薬株式会社 リチウム塩の析出工程を含む、アミノ酸の塩若しくはペプチド化合物の塩又はこれらの溶媒和物の製造方法
JPWO2024080333A1 (cg-RX-API-DMAC7.html) 2022-10-13 2024-04-18

Also Published As

Publication number Publication date
AU2022269959A1 (en) 2023-11-16
CA3219081A1 (en) 2022-11-10
US20220411462A1 (en) 2022-12-29
EP4086272A1 (en) 2022-11-09
TW202309065A (zh) 2023-03-01
JP7165289B1 (ja) 2022-11-02
KR20230003614A (ko) 2023-01-06
KR102569348B1 (ko) 2023-08-21
JPWO2022234864A1 (cg-RX-API-DMAC7.html) 2022-11-10
MX2023013098A (es) 2023-11-16
US20250257094A1 (en) 2025-08-14
WO2022234864A1 (ja) 2022-11-10
US12312379B2 (en) 2025-05-27
JP2022186851A (ja) 2022-12-15
IL307918A (en) 2023-12-01
KR20230169072A (ko) 2023-12-15

Similar Documents

Publication Publication Date Title
ES2310677T3 (es) Composiciones acuosas a base de acido fosforico para la limpieza de dispositivos semiconductores.
HRP20192165T1 (hr) Acesulfam-kalij-pripravci i postupci njihove proizvodnje
EP3636656A4 (en) METHOD OF SYNTHESIS OF PEPTIDE WITH N-SUBSTITUTED AMINO ACID
MX2021006108A (es) Cristal de d-psicosa y procedimiento de preparacion del mismo.
JPWO2023214577A5 (cg-RX-API-DMAC7.html)
AR064968A1 (es) Metodo de preparacion de sucralosa por deacilacion de acilato de 6-sucralosa.
HRP20201626T1 (hr) Pripravci kalijevog acesulfama i postupci za njegovu proizvodnju
BR112013000448A2 (pt) Método para produzir uma composição de fase orgânica para uso na extração com solvente de metais de terras raras da fase aquosa
AR110184A1 (es) FORMULACIONES DE COMPUESTOS DE b-LACTAMA SUSTITUIDOS CON AMIDINA SOBRE LA BASE DE CICLODEXTRINAS MODIFICADAS Y AGENTES ACIDIFICANTES, SU PREPARACIÓN
PE20120223A1 (es) Compuestos heterociclicos como inhibidores del transportador de glicina-1 (glyt-1)
Saavedra et al. Conformation and Chiral Effects in α, β, α-Tripeptides
MY208484A (en) Formulation of contrast media and process of preparation thereof
EA201792640A1 (ru) Устойчивые к действию протеазы липидированные аналоги glp-1
DE50104094D1 (de) Verfahren zur Herstellung von reinem Triethylendiamin (TEDA)
JP2015532915A (ja) ボルテゾミブの製造方法
ME02668B (me) Postupak za izdvajanje nalmefen hidrohlorida
BR112012021940A2 (pt) processo para preparar aminocarboxilatos
ES2278552T1 (es) Preparacion de intermediarios de tadalafil.
US3193510A (en) Alkylsulfate solutions
AR124065A1 (es) Composiciones de lnp que comprenden rna y métodos para preparar, almacenar y utilizar las mismas
AR084098A1 (es) Procesos para la preparacion de enaminas
Zhang Application of fluoroform in trifluoromethylation and difluoromethylation reactions.
DE602005013382D1 (de) Feste formen des magnesiumsalzes von (s)-omeprazol und verfahren zu deren herstellung
DE602007009456D1 (de) Verfahren zur Reinigung von 3-Phenyl-3,4-Epoxy-2-Butanolderivaten durch flüssig-flüssig Extraktion
MX2020004051A (es) Sintesis de icatibant.